GREEN on consultant/specialist initiation: Oral preparation. Cost effective to prescribe generically. For psychosis, bipolar disorder (CG185), depression. (Decision date - October 2022)
RED: Olanzapine LA injection
GREY: Orodispersible sugar-free tablets (Decision date - June 2020)
DO NOT PRESCRIBE (DNP): Not to be prescribed by brand Zyprexa or by using the descriptor 'lyophilisates' which will result in Zyprexa Velotabs being dispensed (Decision date - August 2019)
DO NOT PRESCRIBE (DNP): Orodispersible tablets (unless sugar-free - GREY (see above)) (Decision date - June 2020)
